Articles www.thelancet.com   Vol 381   January 12, 2013 117Lancet 2013; 381: 117â€“24 Published Online November 7, 2012http://dx.doi.org/10.1016/S0140-6736(12)61267-7 See Comment page 93University of North Carolina  School  of Medicine, Chapel Hill,  NC, USA (Prof J B Buse MD);  Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany (Prof M Nauck MD); Institute for Clinical Research and Development, Mainz, Germany (Prof T Forst MD); Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, School of Medicine, National Yang-Ming University, Taipei, Taiwan (Prof W H-H Sheu MD); Eli Lilly and Company, Indianapolis, IN, USA (S K Shenouda PhD, C R Heilmann PhD, B J Hoogwerf MD, M K Boardman PharmD); PharmaNet/i3, Cincinnati, OH, USA (A Gao PhD); Elcelyx Therapeutics, San Diego, CA, USA (M Fineman PhD); Amylin Pharmaceuticals, San Diego, CA, USA (L Porter MD); and